Sinovac Biotech Ltd Cash Flow Quality Index
Sinovac Biotech Ltd cash flow quality index. Sinovac Biotech Ltd (SVA) has a Cash Flow Quality Index of 7.92x as of June 2023. Operating cash flow of $578.90 Million exceeds net income of $73.11 Million, indicating high earnings quality where cash backs reported profits. See how financially flexible is Sinovac Biotech Ltd to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Sinovac Biotech Ltd (2007–2024)
Cash flow quality index of Sinovac Biotech Ltd from 2007 to 2024. Historical Cash Flow Quality Index for Sinovac Biotech Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Sinovac Biotech Ltd to assess how comfortably operating cash covers total debt obligations.
Sinovac Biotech Ltd Cash Flow Quality Index by Year (2007–2024)
Sinovac Biotech Ltd cash flow quality index by year from 2007 to 2024. Year-by-year earnings quality comparison for Sinovac Biotech Ltd. For the full cash flow conversion analysis, see how efficiently does Sinovac Biotech Ltd generate cash.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.63x | $-56.89 Million | $90.91 Million | ▲ +92.8% |
| 2022 | -8.75x | $-770.75 Million | $88.13 Million | ▼ -923.6% |
| 2021 | 1.06x | $15.35 Billion | $14.46 Billion | ▼ -59.0% |
| 2020 | 2.59x | $479.31 Million | $185.18 Million | ▲ +332.0% |
| 2019 | 0.60x | $39.07 Million | $65.22 Million | ▲ +172.4% |
| 2018 | 0.22x | $7.94 Million | $36.11 Million | ▼ -86.5% |
| 2017 | 1.63x | $59.76 Million | $36.70 Million | ▲ +104.5% |
| 2014 | -36.30x | $-10.13 Million | $279.00K | ▼ -7674.6% |
| 2013 | 0.48x | $5.58 Million | $11.64 Million | ▼ -69.9% |
| 2009 | 1.59x | $48.41 Million | $30.41 Million | ▲ +85.1% |
| 2008 | 0.86x | $10.50 Million | $12.22 Million | ▲ +52.4% |
| 2007 | 0.56x | $4.32 Million | $7.65 Million | — |